Cloning ofCYP2J2Gene and Identification of Functional Polymorphisms
- 1 April 2002
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 61 (4) , 840-852
- https://doi.org/10.1124/mol.61.4.840
Abstract
CYP2J2 is abundant in cardiovascular tissue and active in the metabolism of arachidonic acid to eicosanoids that possess potent anti-inflammatory, vasodilatory, and fibrinolytic properties. We cloned and sequenced the entire CYP2J2 gene (∼40.3 kb), which contains nine exons and eight introns. We then sequenced theCYP2J2 exons and intron-exon boundaries in 72 healthy persons representing African, Asian, and European/white populations as part of the National Institutes of Health/National Institute of Environmental Health Sciences Environmental Genome Single Nucleotide Polymorphism Program. A variety of polymorphisms were found, four of which resulted in coding changes (Arg158Cys, Ile192Asn, Asp342Asn, and Asn404Tyr). A fifth variant (Thr143Ala) was identified by screening a human heart cDNA library. All five variant cDNAs of CYP2J2 were generated by site-directed mutagenesis and expressed in Sf9 insect cells by using a baculovirus system. The recombinant wild-type and variant CYP2J2 proteins immunoreacted with peptide-based antibodies to CYP2J2 and displayed typical cytochrome P450 (P450) CO-difference spectra; however, the Asn404Tyr and Ile192Asn variants also had prominent spectral peaks at 420 nm. The ability of these variants to metabolize arachidonic acid and linoleic acid was compared with that of wild-type CYP2J2. Three variants (Asn404Tyr, Arg158Cys, and Thr143Ala) showed significantly reduced metabolism of both arachidonic acid and linoleic acid. The Ile192Asn variant showed significantly reduced activity toward arachidonic acid only. The Asp342Asn variant showed similar metabolism to wild-type CYP2J2 for both endogenous substrates. Based on these data, we conclude that allelic variants of the humanCYP2J2 gene exist and that some of these variants result in a P450 protein that has reduced catalytic function. Insofar as CYP2J2 products have effects in the cardiovascular system, we speculate that these variants may be functionally relevant.Keywords
This publication has 64 references indexed in Scilit:
- Cytochrome P450 CYP2J9, a New Mouse Arachidonic Acid ω-1 Hydroxylase Predominantly Expressed in BrainJournal of Biological Chemistry, 2001
- P450 SUBFAMILY CYP2J AND THEIR ROLE IN THE BIOACTIVATION OF ARACHIDONIC ACID IN EXTRAHEPATIC TISSUES*Drug Metabolism Reviews, 1999
- Cytochrome P450: a novel system modulating Ca2+ channels and contraction in mammalian heart cellsThe Journal of Physiology, 1998
- Mapping of theCYP2JCytochrome P450 Genes to Human Chromosome 1 and Mouse Chromosome 4Genomics, 1998
- Structural Determinants of Progesterone Hydroxylation by Cytochrome P450 2B5: The Role of Nonsubstrate Recognition Site ResiduesArchives of Biochemistry and Biophysics, 1998
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- Leukotoxin, a linoleate epoxide: Its implication in the late death of patients with extensive burnsMolecular and Cellular Biochemistry, 1994
- Genetic polymorphism of cytochrome P4502E1 in a Swedish populationFEBS Letters, 1993
- Association between Restriction Fragment Length Polymorphism of the Human Cytochrome P450IIE1 Gene and Susceptibility to Lung CancerJapanese Journal of Cancer Research, 1991
- Cardiovascular effects of leukotoxin (9,10-epoxy-12-octadecenoate) and free fatty acids in dogsCardiovascular Research, 1988